Press Contact
Ellen Mullally
Phone: 410-992-3124
Email: emullally@paltmed.org
JAMDA
June 16, 2020
Showing 3981 - 3990 of 8082 results
JAMDA
June 16, 2020
Plasma Therapies and Parabiosis in the COVID-19 Era
JAMDA
June 16, 2020
Autonomy Support of Nursing Home Residents With Dementia in Staff-Resident Interactions: Observations of Care
People with dementia living in nursing homes benefit from a social environment that fully supports their autonomy. Yet, it is unknown to what extent this is supported in daily practice. This study aimed to explore to which extent autonomy is supported within staff–resident interactions.
JAMDA
June 16, 2020
High Prevalence of Multidrug-Resistant Organism Colonization in 28 Nursing Homes: An “Iceberg Effect”
Determine the prevalence of methicillin-resistant (MRSA), vancomycin-resistant spp. (VRE), extended-spectrum beta-lactamase producing organisms (ESBLs), and carbapenem-resistant Enterobacteriaceae (CRE) among residents and in the environment of nursing homes (NHs).
JAMDA
June 16, 2020
Gold Standards Framework Can Identify Primary Care Patients Who Would Benefit from a Palliative Approach
Podcast
June 15, 2020
FMDA Journal Club | Telehealth in the Time of Pandemic in PALTC
JAMDA
June 15, 2020
Is There a Link between Nursing Home Reported Quality and COVID-19 Cases? Evidence from California Skilled Nursing Facilities
During the Coronavirus disease 2019 (COVID-19) outbreak in the United States, nursing homes became the hotbed for the spread of COVID-19. States developed different policies to mitigate the COVID-19 risks at nursing homes, including limiting nursing home visitation and mandating staff screening. The purpos...
JAMDA
June 15, 2020
Nursing Home Characteristics Associated With COVID-19 Deaths in Connecticut, New Jersey, and New York
JAMDA
June 15, 2020
The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents
Angiotensin-converting enzyme inhibitors (ACEi), angiotensin II receptor blockers (ARBs), and HMG-CoA reductase inhibitors (“statins”) have been hypothesized to affect COVID-19 severity. However, up to now, no studies investigating this association have been conducted in the most vulnerable and affected po...
JAMDA
June 15, 2020